Skye Bioscience, Inc. — Director's Dealing 2014

Nov 10, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (LGLRD)
CIK: 0001516551
Period of Report: 2014-10-31

Reporting Person: LYKOS COSMAS N (Director, Chairman of the Board, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3374400	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$1.00	2023-06-20	Common Stock (1110000)		Direct

Footnotes

F1: The warrant is immediately exercisable.